And there we have it folks! 🫶🏼💗 #firstword

AI biotech Insilico pulls off long-awaited Hong Kong debut

Firstword Pharma has maybe the simplest, best visual for the $PFE situation. Yes, pharma is hard. Yes, deals & trials fail, but they also surprise & outperform. Pfizer has a dearth of the latter. Arena and SGEN need time, but $1.4B in impairments for Velsipity tells you alot

Our 7-month-old baby girl says Mama now! 😍🖤🥰 👶🤍🌴🌊#firstword #SanClemente #talking

Royalty Pharma locks in full royalty stream from Roche's Evrysdi $PTCT $RPRX

And go! #FirstWord

😍 #TimelineCleanse Do you lead by example? #CuteBaby #FirstWord

Genmab axes late-stage lung cancer bispecific $GMAB

Biohaven's neuropsychiatric hopeful hits another wall $BHVN

छोरोले बाबा भन्न थाल्यो #baba #firstword

St.Valentine gave me such a lovely gift💕 バレンタインデーに届いたなんて嬉しい☺️ #昨日の不在票に今夜を指定したまでです笑 真っ先に聴きたいのは、'Mala'です〜🎺✨ #システム作りがまだです笑 #FirstWord #TakuyaKuroda #RisingSon #reissue #JoeArmonJones #remix

GSK's Exdensur approved in US as first twice-yearly asthma treatment $GSK

Hansa's enzyme therapy falls short in pivotal anti-GBM kidney trial $HNSA

Thank you, FirstWord HealthTech for highlighting Vivoo’s mission to revolutionize wellness. 🎉 Our cutting-edge at-home urine tests and smart health tools are designed to provide rapid, data-driven insights, empowering users to make informed lifestyle and reproductive choices.

Shytoshi: Several community members are highly valued for their hard work and brilliant contributions, including LC, Trophias, Stixil, UB, Baysed, Kraken, Bravo, Firstword, Queenie, and Milkshake. #ShibArmy #shib

Maybe their lack of success is why they’re paying Bloomberg to run a podcast series for them - the hit pieces Bloomberg runs on Rx opioids surely benefits their industry partner. Vertex's pain portfolio is pummeled with setbacks | FirstWord Pharma

Yarrow finds pathway to go public after China licensing deal

पोप लियो XIV के पहले शब्द –”आप सभी के साथ शांति हो!” https://t.co/AqRt62eI5c #popeleo #firstword #peace

Regeneron backs Atavistik's $120M raise to advance small molecule pair $REGN